HOME >> BIOLOGY >> NEWS
Rickets making comeback among breastfed infants, especially blacks, N.C. doctors find

CHAPEL HILL -- North Carolina researchers have discovered new evidence that nutritional rickets, a bone-weakening condition in infants and children caused by too little vitamin D, is making a comeback, especially among breastfed black children. Other dark-skinned children may be at risk for what appears to be a growing, potentially crippling problem, physicians say.

Surprisingly, causes may include more women breastfeeding, fewer infants receiving vitamin D supplements, and mothers and children being exposed to less sunlight than in the past. Breastfeeding still needs to be encouraged, the researchers say, but all dark-skinned, breastfed infants ought to receive vitamin D supplements.

Doctors at the University of North Carolina at Chapel Hill School of Medicine identified and treated 17 cases of nutritional rickets between 1990 and 1999, while colleagues at Wake Forest University School of Medicine found and treated another 13. More than half the cases occurred in 1998 and the first half of 1999. They also received reports of other cases across North Carolina and the nation.

Working together, the researchers described their findings in a paper appearing in the August issue of the Journal of Pediatrics.

"Nutritional rickets, once a major problem in industrialized nations, largely disappeared in this country beginning in the 1930s when it became law that vitamin D had to be added to milk," said Dr. Henry N. Kirkman Jr., Kenan professor emeritus of pediatrics at UNC-CH and an expert on the illness. "The only cases of rickets I treated between 1965 and about 1990 were inherited ones. Then, to my surprise, nutritional rickets began showing up in our clinic in the early 1990s."

Kirkman checked with his counterpart at Wake Forest University, Dr. Robert P. Schwartz, a pediatrics professor who said he also was beginning to see cases of nutritional rickets. All occurred in black children whose mothers had breastfed them.

Besides Schwartz and Kirk
'"/>

Contact: David Williamson
david_williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
9-Aug-2000


Page: 1 2 3

Related biology news :

1. Studies Of A Gene For A Rare Form Of Rickets Shed Light On Vitamin D Deficiencies
2. UCSF Researchers Identify Mutations In Gene Causing Hereditary Form Of Childhood Rickets
3. Brown research reveals key insight into memory-making
4. Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins
5. Scientists, lawyers discuss decision-making amid uncertainty
6. Scientists making advances in cancer prevention, detection and treatment to receive awards
7. Findings could aid efforts to harness nature for making drugs
8. Environment loses to economic development in local policy-making
9. Technological advances making life easier for people with physical and mental challenges
10. The making of a brain
11. Scientists discover role for Cdk4 in making cells cancer resistant

Post Your Comments:
(Date:7/23/2015)... 2015 Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2015.  ... $4.5 million, a decrease of 33% compared to $6.8 million ... second quarter of 2015 was $0.3 million, or $0.01 per ... diluted share, in the same period a year ago.  ...
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Ralco is ... Center at the Lyon County Fair to be held August 5-9 in Marshall. The ... where their meals come from and how agriculture impacts their daily lives. This unique ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... -- Sanofi, a global and diversified ... of 2015. CEO Olivier Brandicourt comments ... different businesses. Watch video interview and ... Topics covered in the interview include:  ... drivers - Diabetes - ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: